HypoTears (Novartis Pharmaceutical Corporation)


Welcome to the PulseAid listing for the HypoTears drug offered from Novartis Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceutical Corporation
NON-PROPRIETARY NAME: polyvinyl alcohol and polyehtylene glycol 400
SUBSTANCE NAME: POLYVINYL ALCOHOL; POLYETHYLENE GLYCOL 400
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2005-07-01
END MARKETING DATE: 0000-00-00


HypoTears HUMAN OTC DRUG Details:

Item DescriptionHypoTears from Novartis Pharmaceutical Corporation
LABELER NAME: Novartis Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 10; 10(mg/mL; mg/mL)
START MARKETING DATE: 2005-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0519_1f11fbef-9c86-c646-a1f9-cdff7fea102f
PRODUCT NDC: 0078-0519
APPLICATION NUMBER: part349

Other POLYVINYL ALCOHOL; POLYETHYLENE GLYCOL 400 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceutical CorporationHypoTears
VITALINE S.A.C.FLORIL TEARS